Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 21;11(2):2328-45.
doi: 10.3390/ijerph110202328.

Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes

Jimmy T Efird  1 , Yuk Ming Choi  2 , Stephen W Davies  3 , Sanjay Mehra  4 , Ethan J Anderson  5 , Lalage A Katunga  6
Affiliations
Review

Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes

Jimmy T Efird et al. Int J Environ Res Public Health. .

Abstract

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Center for Disease Control and Prevention (CDC) National Diabetes Fact Sheet. 2011. [(accessed on 14 December 2013)]. Available online: www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
    1. Garber A.J., Abrahamson M.J., Barzilay J.I., Blonde L., Bloomgarden Z.T., Bush M.A., Dagogo-Jack S., Davidson M.B., Einhorn D., Garvey W.T., et al. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement—Executive summary. Endocr. Pract. 2013;19:536–557. doi: 10.4158/EP13176.CS. - DOI - PMC - PubMed
    1. Shah A.S., Gao Z., Urbina E.M., Kimball T.R., Dolan L.M. Pre-diabetes: The effects on arterial thickness and stiffness in obese youth. J. Clin. Endocrinol. Metab. 2014 doi: 10.1210/jc.2013-3519. - DOI - PMC - PubMed
    1. Milman S., Crandall J.P. Mechanisms of vascular complications in prediabetes. Med. Clin. North Am. 2011;95:309–325. doi: 10.1016/j.mcna.2010.11.004. - DOI - PubMed
    1. Handelsman Y., Mechanick J.I., Blonde L., Grunberger G., Bloomgarden Z.T., Bray G.A., Dagogo-Jack S., Davidson J.A., Einhorn D., Ganda O., et al. AACE task force for developing diabetes comprehensive care plan. American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr. Pract. 2011;17(Suppl 2):1–53. - PubMed

Publication types

LinkOut - more resources